Stocks
Teladoc Health Financial Statements (TDOC) |
||||||||||
| Teladoc Healthsmart-lab.ru | % | 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.03.2021 | 30.09.2021 | 28.02.2022 | 01.03.2023 | 23.02.2024 | 31.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 094 | 2 033 | 2 407 | 2 602 | 2 575 | ||||
| Operating Income, bln rub | -418.2 | -239.0 | 13 198 | -248.6 | -257.8 | |||||
| EBITDA, bln rub | ? | -438.0 | -84.7 | -13 383 | 154.0 | -724.5 | ||||
| Net profit, bln rub | ? | -485.1 | -428.8 | -13 660 | -220.4 | -1 035 | ||||
| OCF, bln rub | ? | -53.5 | 194.0 | 189.3 | 350.0 | 216.7 | ||||
| CAPEX, bln rub | ? | 26.0 | 63.9 | 172.8 | 156.3 | 123.0 | ||||
| FCF, bln rub | ? | -79.6 | 130.1 | 16.5 | 193.7 | 210.9 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 1 121 | 1 621 | 1 890 | 2 091 | 1 719 | |||||
| Cost of production, bln rub | 390.8 | 650.3 | 744.0 | 760.0 | 951.3 | |||||
| R&D, bln rub | 164.9 | 311.9 | 333.6 | 348.5 | 311.9 | |||||
| Interest expenses, bln rub | 60.5 | 80.4 | 9.27 | 22.3 | 22.6 | |||||
| Assets, bln rub | 17 755 | 17 653 | 17 735 | 4 345 | 4 392 | 3 529 | ||||
| Net Assets, bln rub | ? | 15 884 | 15 988 | 16 046 | 2 308 | 2 326 | 1 508 | |||
| Debt, bln rub | 1 465 | 1 297 | 1 267 | 1 573 | 1 592 | 1 589 | ||||
| Cash, bln rub | 786.6 | 826.4 | 896.0 | 918.2 | 1 124 | 1 244 | ||||
| Net debt, bln rub | 678.7 | 470.5 | 371.4 | 655.1 | 468.6 | 345.0 | ||||
| Ordinary share price, rub | 200.0 | 126.8 | 91.8 | 23.7 | 21.6 | 34.9 | ||||
| Number of ordinary shares, mln | 90.5 | 156.9 | 161.5 | 162.2 | 170.2 | |||||
| Market cap, bln rub | 18 098 | 0 | 14 410 | 3 818 | 3 495 | 5 941 | ||||
| EV, bln rub | ? | 18 777 | 470 | 14 782 | 4 474 | 3 963 | 6 286 | |||
| Book value, bln rub | -718 | 1 517 | -369 | -602 | -425 | -272 | ||||
| EPS, rub | ? | -5.36 | -2.73 | -84.6 | -1.36 | -6.08 | ||||
| FCF/share, rub | -0.88 | 0.83 | 0.10 | 1.19 | 1.24 | |||||
| BV/share, rub | -7.94 | -2.35 | -3.73 | -2.62 | -1.60 | |||||
| EBITDA margin, % | ? | -40.0% | -4.17% | -556.1% | 5.92% | -28.1% | ||||
| Net margin, % | ? | -44.3% | -21.1% | -567.5% | -8.47% | -40.2% | ||||
| FCF yield, % | ? | -0.44% | 0.00% | 0.90% | 0.43% | 5.54% | 3.55% | |||
| ROE, % | ? | -3.05% | 0.00% | -2.67% | -591.9% | -9.47% | -68.6% | |||
| ROA, % | ? | -2.73% | 0.00% | -2.42% | -314.3% | -5.02% | -29.3% | |||
| P/E | ? | -37.3 | -33.6 | -0.28 | -15.9 | -5.74 | ||||
| P/FCF | -227.5 | 110.8 | 231.0 | 18.0 | 28.2 | |||||
| P/S | ? | 16.5 | 7.09 | 1.59 | 1.34 | 2.31 | ||||
| P/BV | ? | -25.2 | 0.00 | -39.1 | -6.34 | -8.22 | -21.8 | |||
| EV/EBITDA | ? | -42.9 | -174.6 | -0.33 | 25.7 | -8.68 | ||||
| Debt/EBITDA | -1.55 | -4.39 | -0.05 | 3.04 | -0.48 | |||||
| R&D/CAPEX, % | 633.4% | 487.8% | 193.1% | 222.9% | 253.6% | |||||
| CAPEX/Revenue, % | 2.38% | 3.15% | 7.18% | 6.01% | 4.78% | |||||
| Teladoc Health shareholders | ||||||||||
